Search results for: 'Blood Screening Market'

11 Apr 2024  |  North America  |  Market Research

Global Blood Group Typing Industry, Forecast to 2028

Advancements in Essential Reagents and Automation are Driving Revolutionary Change and Boosting Growth Opportunities

Infographics

×

This study provides an overview of the global blood group typing industry, which is expected to witness significant growth, driven by factors like increased public awareness, improved healthcare infrastructure, government initiatives, and rising per capita income. The increasing prevalence of diseases associated with blood, such as sickle cell anem...

10 Mar 2015  |  North America  |  Market Research

The US Blood Transfusion Diagnostics Market

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

Infographics

×

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and ...

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

14 Jul 2015  |  North America  |  Market Research

Global Airport Passenger Screening Market

An Evolving Market Prepares to Take a Leap Forward into the Future

Infographics

×

The events of 9-11 forever changed how the world views airport security and today serves as the rationale for higher security at airports all over the world. Better technologies and more stringent traveler guidelines were developed because passenger screening serves as a last line of defense. Demand for speedier, more-efficient screening has result...

This research service analyzes the market for high content screening technologies within the United States. The market was divided into the high content screening instrumentation and high content screening reagents and assays segments. Each segment covers market trends, technology trends, competitive structure, market share analysis, revenue foreca...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

Where there is smoke, there is fire. Businesses must recognize DDoS attacks for the data security threat that they are, instead of the simple nuisances of earlier years. In this insight, Stratecast |Frost & Sullivan details the growing threat from smoke screen DDoS attacks, and offers business leaders recommendations for properly understanding DDoS...